(Q40786697)

English

Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

breast carcinoma

1 reference

based on heuristic

inferred from title

author name string

Brockhoff G

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Heiss P

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Schlegel J

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Hofstaedter F

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Knuechel R

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

338-348

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Switching signals on or off by receptor dimerization

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

EGF-induced redistribution of erbB2 on breast tumor cells: flow and image cytometric energy transfer measurements

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Role of HER2 gene overexpression in breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The type I growth factor receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Therapy of metastatic breast cancer with humanized antibodies against the HER2 receptor protein.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Importance of tyrosine phosphatases in the effects of cell‐cell contact and microenvironments on EGF‐stimulated tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Overexpression of the c-erbB-2 protein in human breast tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Only one of the two signals required for initiation of the cell cycle is associated with cellular accumulation of ribosomal RNA

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Zwischenmolekulare Energiewanderung und Fluoreszenz

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Regulation of signal transduction and signal diversity by receptor oligomerization

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

p185HER2 overexpression in human breast cancer using molecular and immunohistochemical methods

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Evaluation of flow-cytometric three-parameter analysis for EGFR quantification and DNA assessment in human bladder carcinomas

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

The prognostic value of c-erbB2 in primary breast carcinomas: A study on 942 cases

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Solution structure of the SH2 domain of Grb2/Ash complexed with EGF receptor-derived phosphotyrosine-containing peptide

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Flow cytometric detection and quantitation of the epidermal growth factor receptor in comparison to Scatchard analysis in human bladder carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

c-erbB-2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1002%2F1097-0320%2820010801%2944%3A4%3C338%3A%3AAID-CYTO1125%3E3.0.CO%3B2-V

21 January 2018

Identifiers

10.1002/1097-0320(20010801)44:4<338::AID-CYTO1125>3.0.CO;2-V

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40786697&oldid=2039017853"